Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Pulsed electric field treatment may help shrink untreated liver tumors.

JAK inhibition reduces autoimmune issues in Down syndrome.

Upadacitinib improved multiple immune-related conditions in one patient.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Familial dyskeratotic comedones are a rare, inherited skin condition that is hard to treat but may improve slightly with topical retinoids and urea cream.

EK significantly improved wound healing and reduced infection in burn wounds.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

ALEP is a drug-triggered skin reaction with pustules that clears up in a week after stopping the drug.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

A new wearable LED device helps heal chronic infected wounds at home.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Finasteride can cause a unique skin reaction on the penile shaft.

Topical IKKα inhibitors may help prevent CCS tumours.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Combining fire needle therapy with doxycycline improves severe acne more than doxycycline alone.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Stopping afatinib improved a rare scalp condition in a patient.

Baricitinib effectively regrew hair in a woman with alopecia universalis after other treatments failed.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

Nilotinib can cause skin issues like red bumps and hair loss.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

Topical dapsone gel reduced flare-ups in folliculitis decalvans without side effects.